Login
Subscribe
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
celgene
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Katarina Zimmer | Jan 22, 2018 | 2 min read
Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.